a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options
Industry Biotechnology
A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.
Ticker / NAME | Correlation To PASG | 1D Price Change % | ||
---|---|---|---|---|
PASG | 100% | -12.06% | ||
AXON - PASG | 43% Loosely correlated | -0.86% | ||
CYTK - PASG | 38% Loosely correlated | -8.19% | ||
ARRY - PASG | 35% Loosely correlated | -10.22% | ||
CMPX - PASG | 33% Poorly correlated | -13.21% | ||
SNPX - PASG | 32% Poorly correlated | -8.05% | ||
More |